Background: Although the existence of cholecystokinin-like immunoreactivity (CCK-LI) in rat pancreas had been reported previously, it was never clearly demonstrated whether CCK is produced in rat pancreatic islets. Aims: The purpose of this study was to elucidate the source of the CCK-LI, the molecular properties of CCK, and the expression of the CCK gene in islet cells. Methods: Immunohistochemical studies of rat pancreas were carried out with different rabbit antisera against CCK-8 and CCK-related peptide including N-terminal CCK-33 (1-22) and gastrin-17, and colocalization with known islet hormones including insulin, glucagon, somatostatin, and pancreatic polypeptide was investigated. The major molecular form of CCK in the islets was determined by HPLC. RT-PCR and in situ hybridization were performed to demonstrate the presence of the CCK transcript in the pancreas. Results: CCK-LI was found in the center of the islets, colocalized with insulin in B cells. The major molecular form of CCK in the islets was CCK-8. A 350-nucleotide fragment of PCR-amplified CCK cDNA was detected in the islet as well as the duodenum by RT-PCR. In situ hybridization showed that CCK messenger RNA was located in a large portion of the islets, and this was consistent with the immunohistochemical findings. Conclusion: CCK messenger RNA and immunoreactivity are expressed in adult rat pancreatic islets, indicating that CCK-producing cells are present in adult rat islets. (Endocrinology 139: 389 -396, 1998) R ECENTLY, certain gastrointestinal hormones, including gastrin (1-3), secretin (4), peptide-YY (PYY) (5, 6), and thyroxin-releasing hormone (TRH) (7), have been found to be present in the islets of Langerhans. Although these hormones are highly expressed during the late gestational stage, they rapidly diminish and are no longer present in adulthood. Cholecystokinin (CCK) was originally discovered in the mucosa of the upper small intestine (8) and was subsequently found in the central nervous system (9). CCK exerts several biological actions: stimulation of pancreatic enzyme secretion (10), contraction of the gallbladder (11), the release of insulin (12, 13), and differentiation and growth of the pancreas (14). Sulfated CCK-8 (12) and CCK-4 (13) are the forms of CCK that have been shown to stimulate insulin release. In addition, CCK receptor antagonist has been found to significantly inhibit exocrine pancreatic secretion in response to vagal stimulation in the isolated vascularly perfused rat pancreas with the duodenum excluded (15). Besides the humoral regulation, CCK-containing nerve was found in the pancreas of cats, pigs, hamsters, (13, 16 -18) and camels (19), but not snakes (20). These findings suggest that CCK may exist in the pancreas and exert a significant effect on endocrine and exocrine function via a paracrine, an autocrine, or a neurocrine action. While CCK-like immunoreactivity (CCK-LI) has been found in the islets in the normal rat and human pancreas (21), and in human glucagonoma (22, 23), it has never been determined whether CCK is synthesized in the islets. In the present study, we demonstrate CCK gene expression and immunoreactivity in the islets and characterize the molecular form of CCK in the rat pancreas by HPLC.
R ECENTLY, certain gastrointestinal hormones, including
gastrin (1-3), secretin (4), peptide-YY (PYY) (5, 6) , and thyroxin-releasing hormone (TRH) (7) , have been found to be present in the islets of Langerhans. Although these hormones are highly expressed during the late gestational stage, they rapidly diminish and are no longer present in adulthood. Cholecystokinin (CCK) was originally discovered in the mucosa of the upper small intestine (8) and was subsequently found in the central nervous system (9) . CCK exerts several biological actions: stimulation of pancreatic enzyme secretion (10) , contraction of the gallbladder (11) , the release of insulin (12, 13) , and differentiation and growth of the pancreas (14) . Sulfated CCK-8 (12) and are the forms of CCK that have been shown to stimulate insulin release. In addition, CCK receptor antagonist has been found to significantly inhibit exocrine pancreatic secretion in response to vagal stimulation in the isolated vascularly perfused rat pancreas with the duodenum excluded (15) . Besides the humoral regulation, CCK-containing nerve was found in the pancreas of cats, pigs, hamsters, (13, 16 -18) and camels (19) , but not snakes (20) . These findings suggest that CCK may exist in the pancreas and exert a significant effect on endocrine and exocrine function via a paracrine, an autocrine, or a neurocrine action. While CCK-like immunoreactivity (CCK-LI) has been found in the islets in the normal rat and human pancreas (21) , and in human glucagonoma (22, 23) , it has never been determined whether CCK is synthesized in the islets. In the present study, we demonstrate CCK gene expression and immunoreactivity in the islets and characterize the molecular form of CCK in the rat pancreas by HPLC.
Materials and Methods

Preparation of tissues and sections
Adult male Wistar rats weighing 300 g were anesthetized with pentobarbital (40 mg/kg) and fixed by intra-aortic perfusion of isotonic saline (200 ml) followed by 400 -500 ml of freshly prepared 4% paraformaldehyde in PBS (pH 7.2). Representative regions of the pancreas were removed and stored in the same fixative overnight before routine paraffin wax processing. The paraffin-embedded tissue was cut into 4-m sections on silane-coated slides. The sections were then deparaffinized and rehydrated through a clean xylene and ethanol series.
Isolation of intact islets
Intact islets of Langerhans were isolated from adult male Wistar rats weighing 200 -300 g according to the method of Lacy et al. (24) . After anesthetizing the animals with ip and im injections of urethane (50% wt/vol, 0.5 ml/100 g BW), the distal end of the pancreatic duct adjacent to the duodenum was clamped and a polyethylene tube (PE-50, 0.58 mm ID) was inserted into the common bile duct near the hilus of the liver. The abdominal aorta was cannulated with a polyethylene tube (PE-50, 0.58 mm ID) below the renal arteries and the portal vein was sectioned. A 0.15 m NaCl solution was infused into the aorta to flush the blood out of the pancreas. Collagenase solution (50 mg of collagenase type V (Worthington Biochemical Corporation, Freehold, NJ) dissolved in 5 ml of HBSS was injected into the common bile duct. Approximately 10 min after the injection of collagenase, the whole pancreas was carefully removed and placed in a test tube containing the collagenase solution described above. The tube was shaken vigorously by a hand in a 37°C water bath for 5 min until no tissue pieces were visible on the wall of the tube, and the digested pancreas was then washed three times with HBSS. The sediment containing the islets was suspended in 30% (wt/wt) Ficoll (Sigma Chemical Co., St. Louis, MO). This was layered over a discontinuous Ficoll gradient consisting of 4 ml each of 20%, 23%, and 27% Ficoll in HBSS (wt/wt). After centrifugation of the discontinuous gradients at 700 ϫ g for 10 min, the islets were withdrawn from the interface between the 20% and 23% Ficoll layer, fixed in 4% paraformaldehyde overnight, and embedded in paraffin for in situ hybridization.
Immunohistochemical study
Adjacent pairs of the sections were mounted on separate slides as the mirror images for colocalization studies of CCK and insulin, glucagon, somatostatin, and pancreatic polypeptide (PP). The immunohistochemical protocol used was basically the avidin-biotin complex (ABC) method with reagents provided by Vector Laboratories, Inc. (Burlingame, CA). Anti-CCK-8 antiserum was raised with BSA-CCK-8 conjugate and had a final titer of 1:1,000,000. The antiserum has the following relative reactivity toward various CCK/gastrin family peptides: CCK-8, 100%; unsulfated CCK-8, 50%; porcine CCK-33, 33%; canine CCK-58, 20%; CCK-27-33 (CCK-7), 50%; CCK-28-33 (CCK-6), 2.5%; CCK-4, Ͻ0.1%; human gastrin-17-I, 0.3%. The antiserum does not cross-react with other islet peptides including insulin, glucagon, PP, and somatostatin at concentrations as high as 10 m. The sharp decrease in cross-reaction with unsulfated CCK-8, CCK-6, and CCK-4 indicated that the antibody reacts predominantly with an epitope involving the Nterminal region of CCK-8 that contains the sulfated tyrosine residue. Anti-CCK 1-22 was raised against the N-terminal 1-22 fragment of porcine CCK-33 to a titer of 1:250,000 and reacts exclusively toward porcine CCK-33. Primary antisera included rabbit anti-CCK-8 and anti-N-terminal CCK-33 (CCK 1-22) at 1:1000 dilution; rabbit antihuman gastrin-17, rabbit antiporcine insulin, rabbit antihuman gastrin-17, rabbit antiporcine insulin, rabbit antiporcine glucagon, rabbit antihuman somatostatin, and rabbit antihuman PP at 1:100 dilution (Vector). After incubation with the antiserum at 4 C overnight, a biotinated goat antirabbit serum IgG (Vector) was used as the second antibody. Peroxidase staining was performed with 3,3Ј-diaminobenzidine (DAB).
In order to clarify the localization of CCK in the islets, double immunohistochemical staining was performed with ABC method using CCK antiserum followed by horseradish peroxidase-antiperoxidase (PAP) method using insulin, glucagon, somatostatin, PP, or gastrin antisera. The primary antibodies used were described above. Immunoperoxidase staining for CCK was detected by ABC method using aminoethylcarbazole (AEC). After the observation, these slides were treated in 0.01 m citrate buffer (pH 6.0) at 90 -95 C for 10 min before the second immunoperoxidase staining for insulin, glucagon, somatostatin, PP, and gastrin. The localization of these endocrine hormones were detected by PAP method using DAB.
The absorption studies used CCK-8 antiserum absorbed with 10 m CCK-8 or 100 m gastrin (Sigma Chemical Company). After preincubation of the CCK-8 antiserum with CCK-8 or gastrin overnight, the supernatant was used as the primary antiserum.
HPLC of rat pancreas extracts
Pancreata were quickly removed from eight anesthetized rats and immediately boiled for 10 min. They were then homogenized in a Polytron tissue homogenizer, and the pH of the homogenate was adjusted to 9.2 with aqueous ammonia. 2-mercapto-ethanol was added to a final concentration of 0.05%, and stirring was performed for 2 hours at 4 C. After a lipid layer had been separated out by centrifugation at 12,000 ϫ g at 4 C and removed, the supernatant was lyophilized and extracted with a C18 Sep-Pak cartridge. The molecular heterogeneity of the CCK-LI in the C18 Sep-Pak extract was analyzed by reverse-phase HPLC on a Varian MCH10 C18 analytical column (4.6 ϫ 300 mm), as described previously (25).
RT-PCR
Total RNA was extracted from the isolated islets and the duodenum by the method of Chomczynski (26) and quantified by measuring the absorbance at 260 nm. The RT reaction was carried out in a 20 l volume, containing 4 l of 5 ϫ RT buffer, 1 l of deoxyribonucleotide triphosphate (dNTP, 25 mm each), 100 pmol of random hexamer, 1 U/g of RNase inhibitor, 1 g of total RNA, and 200 U Moloney murine leukemia virus (M-MuLV) reverse transcriptase. The reaction mixture was incubated at 37 C for 60 min, heated to 95 C for 10 min and then quickly chilled on ice. One tenth of the resulting complementary DNA (cDNA) was used as a template for the PCR. PCR was done in a final volume of 20 l, containing 3 mm MgCl 2 , 50 m of each dNTP, 50 pmol each of the up and downstream primers, and 2 U Thermus Aquatics (Taq) DNA polymerase. Oligonucleotide primers were designed on the basis of the DNA sequence of rat CCK. Amplification of cDNA with primers located in exon 2 and exon 3 of the gene expected to yield a specific PCR product of 350 bp. The sequences of the upstream primers was 5Ј-CAAGATC-TATGAAGTGCGGCGTGT-3Ј, and the downstream primer was 5Ј-GGCGGATCCACTACGATGGGTA-3Ј. A thermal cycle program of 40 cycles of 45 sec at 94 C, 45 sec at 60 C, and 2 min at 72 C was employed. The products were separated by electrophoresis on a 2% agarose gel and visualized with ethidium bromide.
Restriction digestion by endonuclease
The amplified PCR products from islet and duodenum were purified by Magic PCR Prep (Promega, Madison, MI) to remove the excess primers. The purified PCR products were digested by HAE III at 37 C for 1 h. The digested PCR products were electrophoresed on a 2% agarose gel containing ethidium bromide.
Southern blot analysis
PCR amplified products from islets and duodenum were electrophoresed on a 2% agarose gel containing ethidium bromide. The agarose gel was denatured in 0.5 n NaOH and 1.5 m NaCl, and was neutralization in 1.0 m Tris-HCl, pH 8.0, 1.5 m NaCl for 60 min at room temperature with gentle agitation. Then the DNA was transferred to a nylon membrane. The membrane was prehybridized for 2 h at 65 C in standard prehybridization solution. A CCK specific cDNA was labeled with digoxigenin (DIG)-11-dUTP (Boehringer Mannheim Corporation, Indianapolis, IN) using the random primer method. Hybridization with DIG-labeled CCK cDNA probe was carried out in the standard prehybridization solution at 65 C overnight. The membrane was washed twice with 2 ϫ SSC containing 0.1% SDS at 65 C. These hybridized probe was immunodetected with an alkaline phosphatase-conjugated antidigoxigenin antibody and visualized colorimetrically using NTB and X-phosphate substrate.
In situ hybridization
An EcoR1-Hind III restriction fragment of the plasmid containing the cDNA encoding rat preprocholecystokinin was labeled by random primed DNA labeling with digoxigenin dUTP using a Genius DNA labeling kit (Boehringer Mannheim). The slides were immersed in 0.2 n HCl at room temperature for 15 min and transferred into 2 ϫ SSC at 70 C for 30 min. The sections were then digested in proteinase K solution at a concentration of 10 g/ml in 20 mm Tris-HCl (pH 7.4) at 37 C for 60 min. After digestion, the sections were washed in PBS and fixed with 4% paraformaldehyde in PBS at room temperature for 5 min. Following fixation, the sections were washed in PBS and dehydrated in 100% ethanol and air dried, and then immersed in 0.25% acetic anhydride containing 0.1 m triethanolamine at room temperature for 10 min. As a negative control, RNase (1 mg/ml) pretreatment was carried out at this stage. The sections were washed in 2 ϫ SSC and then in diethylpyrocarbonate (DEPC)-treated water, and after dehydration in 100% ethanol and air-drying, they were incubated at 42 C for 2 h in hybridization buffer consisting of 50% formamide, 5 ϫ SSPE (900 mm NaCl, 50 mm NaH 2 PO 4 , 5 mm EDTA, pH 7.4), 5 ϫ Denhardt's solution, 0.1% SDS, and sonicated salmon sperm DNA. Plasmid containing the cDNAs encoding rat preprocholecystokinin (Dr. J. Dixon, University of Michigan) (27), preprogastrin (28), and preproinsulin were labeled with digoxigenin (DIG)-11-dUTP by the PCR method. For hybridization, each digoxigenin-labeled cDNA probe was added to hybridization buffer containing 50% dextran sulfate, and the sections were then incubated at 42 C overnight. As a negative control, unlabeled CCK cDNA was hybridized overnight before the hybridization with labeled CCK probe. Following hybridization, the sections were washed in 2 ϫ SSC at room temperature for 60 min, then in 50% formamide containing 1 ϫ SSC at 45 C for 20 min, and briefly in 2 ϫ SSC at room temperature. Color detection was per-formed according to the standard procedure for the nonradioactive DNA detection kit (Boehringer Mannheim). Briefly, the sections were immersed in 100 mm Tris-HCl (pH 7.5) and 15 mm NaCl, and incubated with blocking solution consisting of 2% normal sheep serum, 0.3% Triton X-100, 100 mm Tris-HCl (pH 7.5), and 15 mm NaCl at room temperature for 30 min. They were then incubated with the antidigoxigenin Fab fragment conjugated to alkaline phosphatase at 4 C overnight. After incubation, the sections were washed in 100 mm Tris-HCl (pH 7.5), 150 mm NaCl followed by 100 mm Tris-HCl (pH 9.5), 100 mm NaCl, and 50 mm MgCl 2 . The antidigoxigenin alkaline phosphatase activity was detected with X-phosphate and NTB.
Results
CCK and insulin-like immunoreactivity was found evenly in the cells localized in the center of the islets (Fig. 1) . Neither CCK-containing nerve fibers nor nerve cell bodies were observed in the rat pancreas. CCK-LI-positive cells had round nuclei and cytoplasm filled with granules of uniform size. Based on the number and pattern of distribution of these cells, they appeared most likely to be insulin-containing B cells. Glucagon-LI cells (A cells) were situated in the periphery (mantle area) of the islets. Somatostatin cells (D cells)
were seldom encountered and were interposed between the insulin and glucagon cells. PP-containing cells were distinct from the A, B, and D cells and were located in the periphery of the islets and scattered among the exocrine cells. The mirror sections of rat pancreas were processed with CCK-8 and the other endocrine hormone antisera to confirm the identity of CCK-LI and the other endocrine hormones. Sections immunostained for insulin revealed positive cells with characteristics identical to those that stained positive for CCK-8 (Fig. 1A-INS, 1A-CCK) . The other cells containing glucagon (Fig. 1B-GLU, 1B-CCK), somatostatin (Fig. 1C-SOM, 1C-CCK) , and PP (Fig. 1D-PP, 1D -CCK) were completely different from the CCK-cells. No positive staining was observed in the islets with either antiserum to N-terminal CCK-33 (CCK 1-22) or gastrin-17 antiserum. The double staining studies also confirmed that CCK-LI was colocalized with insulin ( Fig. 2A-INS CCK-LI in the islets was completely abolished by preabsorption of the CCK antiserum with CCK-8 but not with gastrin (Fig. 3) .
The C18 Sep-Pak extracts of rat pancreas yielded the major peak of CCK-LI with a retention time of 30 min, corresponding to the sulfated CCK-8 standard. There were no significant peaks of either gastrin-17 or gastrin-34 (Fig. 4) . The mean CCK-8 concentration in the whole pancreas was 463 Ϯ 59 pmol/g wet tissue (n ϭ 6).
Expression of CCK mRNA in the islets was detected by RT-PCR. RNA was extracted from the islets and the duodenum, and cDNA was obtained from each by RT. Amplification of cDNA with primers located in exon 2 and 3 on the CCK gene yielded a specific PCR product of 350 bp (Fig. 5A) . Restriction digestion pattern of PCR fragments from these two sources were identical (Fig. 5B) . To further confirm that the PCR product was derived from CCK messenger RNA (mRNA), the amplified cDNA was transferred to nylon membrane and hybridized with a digoxigenin labeled CCKspecific cDNA probe. The CCK cDNA probe identified a single DNA of 350 bp in PCR products from islets and duodenum by Southern blot analysis (Fig. 5C ).
We performed in situ hybridization using a CCK cDNA probe to identify the location of CCK gene expression in the islets. CCK mRNA signals were clearly demonstrated diffusely throughout the large portion of the islets, which is consistent with the location of CCK-LI-containing cells that we observed previously (Fig. 6, A and B) . As a positive control, insulin mRNA was seen diffusely in the center of the islet (Fig. 6, C and D) . There was no gastrin mRNA signals in the islet (Fig. 6E) . As a negative control, the prehybridization with unlabeled CCK cDNA before hybridization with the CCK probe completely abolished the hybridization signal (Fig. 6F) .
Discussion
Although CCK-LI has been demonstrated in the pancreatic islets by immunohistochemical studies (13, 21) , the existence of CCK-producing cells in the pancreas had never been established. To identify CCK-producing cells in the pancreas, we examined the rat pancreas for the presence of CCK-LI and CCK transcripts.
In the present study, CCK-LI was detected in the central portion of the islets by immunohistochemical studies. Analysis of mirror section and double staining clearly demonstrated that CCK and insulin immunoreactivity coexisted in the same cells. Glucagon, somatostatin, and PP cells, on the other hand, were located in the periphery of the islets. There was no gastrin immunoreactivity in the whole islets. CCK antiserum saturated with CCK showed no immunoreactivity in the immunohistochemical study, and CCK antiserum incubated with rat gastrin failed to abolish CCK-LI in the islets. Cross-reactivity of CCK antiserum with the related peptide gastrin makes it difficult to segregate the CCK-LI from gastrin-LI. CCK-8 is partially homologous with gastrin, with the two sharing a C-terminal pentapeptide (Gly-Trp-Met-AspPhe-NH 2 ). To distinguish the CCK-LI in the islets as CCK-8 rather than gastrin, we used three different rabbit antisera: antiserum against CCK-8, N-terminal CCK-33 (CCK1-22), and gastrin-17. Strongly positive staining was observed only with the anti-CCK-8 serum, indicating that the CCK-LI in the islets most likely represented CCK-8. It has been previously reported that gastrin is maximally expressed in the islets during late fetal gestation and rapidly disappears during the first week after birth (2, 3) . This also supports our observations. Due to the low cross-reactivity toward CCK-4, we were unable to detect neurons or nerve fibers in the pancreas containing this form of CCK (13) using our CCK-8 antiserum.
Moreover, HPLC analysis of the pancreatic extracts failed to detect gastrin. In the HPLC analysis of pancreatic extracts, 5 . Analysis of CCK mRNA from rat pancreatic islet and duodenum by RT-PCR in A. Total RNAs were extracted from isolated islets (I) and duodenum (D) of adult male rats. One microgram of total RNA from each source was reverse transcribed and amplified by a PCR using CCK specific primers. Restriction digestion of PCR products by HAE III (B). The amplified PCR products from islets and duodenum using CCK specific primers, were digested by HAEIII. These products were electrophoresed on a 2% agarose gel containing ethidium bromide. Lane M: 1 kb DNA ladder size marker. Southern blot analysis of PCR amplified products from islets and duodenum (C). PCR amplified products from islets and duodenum were electrophoresed on a 2% agarose gel containing ethidium bromide. After denaturation, the DNA was transferred to a nylon membrane. The membrane was hybridized with DIG-labeled CCK cDNA probe at 65 C. Detection was performed colorimetrically using nitroble tetrazolium (NTB) and 5Ј-bromo-4 choloro-3-indobyl phosphate (X-phosphate).
standard CCK-8 (5 ng), pCCK-33 (10 ng) and cCCK-58 (20 ng) were run though the same column individually and in combination under the same chromatographic conditions and then detected by RIA to obtain their retention times. Both CCK-7 (20 ng) and CCK-6 (100 ng) exhibited a retention time of 28 min when run individually. Therefore, except for the peak eluted at 10 min, which had the same retention time as that of oxidized CCK-8 (prepared by oxidation of CCK-8 with dithionate), we were unable to identify the other forms of CCK-LI in the pancreatic extract that were eluted at 24 min or earlier. When applied at 100 ng, CCK-4 exhibited a very small immunoreactive peak eluted at 34 min and thus could represent the small peak eluted after but not well resolved from CCK-8 that was occasionally found in the pancreatic extract. Because CCK-4 was found in the islet endocrine cells only in feline pancreas (13) , it was possible this peak represent CCK-4 in the pancreatic neurons of rat pancreas. Due to the low yield of isolated islet, we did not study the molecular form of CCK-LI in the endocrine pancreas. However, the results of immunohistochemical study indicated that only the islet endocrine cells contained CCK-LI recognizable with our antiserum, it is logical to assume that the form of CCK-LI detected in the pancreatic extract represented those detected in the endocrine cells. However, we cannot rule out the presence of CCK-4 containing nerve fibers in the islet as observed by Rehfeld et al. (13) in other species.
FIG. 6.
In situ hybridization using digoxigenin-labeled CCK cDNA probe, insulin cDNA probe, and gastrin cDNA probe on isolated rat islets of Langerhans. The sections were hybridized with each probe at 42 C overnight. As a negative control, unlabeled CCK cDNA was hybridized overnight before the hybridization with labeled CCK probe. The hybridized probe was immunodetected with an alkaline phosphataseconjugated antidigoxigenin antibody and visualized colorimetrically using Xphosphate and NBT. CCK mRNA was observed diffusely throughout the islets (ϫ66; ϫ160). As a positive control, insulin mRNA was identified in the center of the islet (ϫ66; ϫ160). On the other hand, there was no gastrin mRNA in the entire islets (ϫ66). The pretreatment with unlabeled CCK cDNA before the hybridization with labeled CCK probe, completely abolished the CCK mRNA signals (ϫ66).
Examination of the rat pancreas by in situ hybridization and RT-PCR revealed that the CCK gene was expressed in the islets of adult rats. The CCK gene was expressed in the islets, corresponding to those observed with mRNA from the duodenal mucosa by RT-PCR. The restriction digestion pattern and Southern blot analysis of the PCR amplified cDNA from the islet and the duodenum strongly suggest that this is the product of authentic CCK mRNA.
The CCK mRNA was observed diffusely in the islet by in situ hybridization as well as CCK-LI detected by immunohistochemical studies. Insulin mRNA was also clearly demonstrated in the center of the islet; on the other hand, there was no gastrin mRNA in the whole islet by in situ hybridization. The preabsorption study with unlabeled CCK cDNA before the hybridization with labeled CCK cDNA probe confirmed the existence of CCK mRNA in the islet. These results suggest that the cells expressing the CCK gene are also able to translate CCK mRNA.
Madsen et al. (22) reported a cloned cell line from a transplantable radiation-induced islet cell tumor that coexpressed CCK and glucagon, and CCK mRNA was revealed by Northern blot analysis in a human glucagonoma but not in insulinoma or normal pancreatic tissue. Grube (21) et al. also demonstrated colocalization of CCK-LI with glucagon in A-cells in adult rat and human pancreatic islets. These observations suggest that CCK is synthesized in A cells, but that is inconsistent with our own findings. Although CCK-LI was found in the intrapancreatic nerve fibers or A cells in the pancreas, it has never been reported the presence of CCK in B cells. The discrepancy between our observation and the previous other studies might depend on the species, age, and antibody used. In the present study, neither CCK-containing nerve fiber nor ganglia was found in the rat pancreas. Also, the characteristics of islet cell tumors may be different from that of normal tissue.
Pancreatic endocrine cells appear to arise from the multipotential stem cells. Several gastrointestinal hormones, such as gastrin (1-3), secretin (4), PYY (5, 6) , and TRH (7), have been reported to be present in the pancreatic islets during the developmental period. These gastrointestinal hormones, including glucagon, are maximally expressed during late gestational period and rapidly disappear after birth. This suggests that gene expression of the gastrointestinal hormones in pancreatic islets are developmentally regulated and may influence pancreatic differentiation and growth. On the other hand, a large portion of the islets expressed both CCK mRNA and CCK immunoreactivity as well as insulin in the adult, suggesting that CCK may contribute to pancreatic growth or physiological regulation. In single-pass, isolated vascularly perfused rat pancreas with the duodenum excluded, the CCK-A antagonist L-364718 was shown to inhibit the flow of pancreatic juice and amylase output in response to vagal stimulation (15) . This suggested that the inhibition is attributable to local release of CCK in the pancreas. CCK/gastrin immunoreactive nerves innervated both ganglionic cells and glucagon cells in the islets of the hamster, porcine, and feline pancreas (13, 16, 17) . These nerve were found to be extrinsic (13) and thus could not be the source of CCK mRNA. Further, more recent study suggested that CCK immunoreactive ganglion cells were found in the feline pancreas (18) . These observation indicated that CCK may act as a neurotransmitter in the pancreas. On the other hand, we could identify CCK-8 immunoreactivity and its transcript in B cells but neither in the nerve terminals nor in the ganglia in the rat pancreas. This observation suggests CCK is expressed and synthesized in the islet B cells that may have a distinct function from the extrinsic CCK-containing nerves found in other species.
Morphological studies indicate that numerous efferent vessels from the islets reach the acinar and duct cells, and thus that the exocrine pancreas receives significant blood flow from the islet-acinar portal system in the horse (29), rat (30), human (31), and monkey (32, 33), and local delivery of islet hormones via islet-acinar portal vessels may stimulate pancreatic exocrine secretion. The previous studies reported that a peptide corresponding to the C-terminal tetrapeptide amide (CCK-4) of CCK/gastrin was present in the nerve terminals in the hamster, pig, and cat (13, 16 -18) and camel (19) , but not in the snake (20) . While CCK-4 in the nerve is thought to be an insulin releaser in isolated perfused porcine pancreas (13) , others have reported that CCK-8 or CCK with longer amino acid residues are more potent stimulant of insulin release in the perfused rat pancreas (12) . It is possible that CCK-8 in the islets may be involved not only in the release of insulin but also in the stimulation of exocrine pancreatic secretion in the rat.
In conclusion, we have presented evidence that the CCK gene is expressed in rat pancreatic islets and that CCK-LI is colocalized with insulin, indicating that CCK is synthesized in the islets of Langerhans. The main molecular form of CCK-LI in the pancreas is CCK-8. While the physiological role of CCK in the islets has not yet been characterized, CCK in the islets may play an important role in pancreatic exocrine and endocrine secretion.
